Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

49

Revenue 2017

Janumet

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Janumet was produced by Merck & Co..

Merck pulls Keytruda filing in Europe, despite US approval

Merck pulls Keytruda filing in Europe, despite US approval

portfolio after its Januvia/Janumet diabetes franchise.

FDA won't add outcomes data to Januvia label

FDA won't add outcomes data to Januvia label The US regulator has sent the pharma company a complete response letter for DPP-4 inhibitor Januvia (sitagliptin) and combination product Janumet (sitagliptin plus metformin) - along with extended release formulations - saying

Merck drops once-weekly diabetes drug in US and EU

Merck drops once-weekly diabetes drug in US and EU Januvia and companion drug Janumet (sitagliptin plus metformin) brought in revenues of just over $6bn last year, in line with 2014, and the once-buoyant growth of the franchise has been

Dr Susanne Fiedler takes over as CEO of MSD Germany

Dr Susanne Fiedler takes over as CEO of MSD Germany Since then Dr Fielder has served in the US, where MSD operates at Merck &Co, as global brand leader for the diabetes treatments Januvia and Janumet, before taking up a

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales Merck meanwhile posted revenues of $10.07bn, a 2% increase, with its Januvia (sitagliptin) and Janumet (sitagliptin and metformin) diabetes franchise leading the charge with sales 9% to $1.01bn and

1 2 3 4 5 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics